Dr. Tantravahi has received his medical degree from Guntur medical college, India. He then completed an Internal Medicine residency and Hematology and Oncology fellowship training at the University of Utah Hospital. His clinical interests include multiple myeloma, stem cell transplantation, and myeloproliferative neoplasm. The focus of his research has been on the mechanisms of resistance of CML patients to tyrosine kinase inhibitor therapy. Sri and his colleagues demonstrated that TKI resistance arises from both mutations in the BCR-ABL1 kinase and other cellular pathways. Through his research on chronic myeloid leukemia, he successfully leveraged a competitive Research Training Award from the American Society of Hematology to extend his research work. During his residency and fellowship, Dr. Tantravahi published 14 manuscripts in peer-reviewed journals. His clinical work at Huntsman Cancer Institute includes chronic myeloid malignancies, multiple myeloma, and bone marrow transplantation.